TANAKA SACHIKO 田中祥子

… Alternative Names

田中祥子タナカサチコ

TANAKA Sachiko 田中祥子

Less

Researcher Number	50328556
Other IDs
Affiliation (Current)	2025: 東京薬科大学, 薬学部, 助教
Affiliation (based on the past Project Information) *help	2023: 東京薬科大学, 薬学部, 助教 2019 – 2021: 東京薬科大学, 薬学部, 助教 2012 – 2014: 東京薬科大学, 薬学部, 助教
Review Section/Research Field	Principal Investigator Basic Section 47060:Clinical pharmacy-related / Medical pharmacy
Keywords	Principal Investigator 重症筋無力症 / 免疫寛容誘導 / 腸管免疫 / 乳由来エクソソーム / 重症筋無力症患者 / プレシジョンメディスン / エピジェネティック制御 / 制御性T細胞 / 重症筋無力症状 / オーダーメイド療法 … More / カルシニューリン阻害剤 / 副腎皮質ステロイド剤 / CD25+Foxp3+CD4+制御性T細胞 / CD24+CD38+CD19+制御性B細胞 / IL-10 / 免疫寛容 / B細胞活性化因子 / 制御性B細胞 Less

Research on Milk Exosome for Induction of Intestinal Immune TolerancePrincipal Investigator
- Principal Investigator
  
  田中祥子
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Tokyo University of Pharmacy and Life Science
Regulatory T cells and their Potential for Tolerance Induction in Myasthenia Gravis Towards Precision MedicinePrincipal Investigator
- Principal Investigator
  
  TANAKA SACHIKO
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Tokyo University of Pharmacy and Life Science
Induction of Peripheral immune tolerance in Myasthenia Gravis PatientsPrincipal Investigator
- Principal Investigator
  
  TANAKA Sachiko
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Tokyo University of Pharmacy and Life Science

All 2023 2019 2015 2014 2012 Other

All Journal Article Presentation

[Journal Article] Arsenic disulfide combined with L-buthionine-(S, R)-sulfoximine induces synergistic antitumor effects in two-dimensional and three-dimensional models of MCF-7 breast carcinoma cells2019
- Author(s)
  Yuxue Zhao, Sachiko Tanaka, Bo Yuan, Kentaro Sugiyama, Kenji Onda, Anna Kiyomi, Norio Takagi, Munetoshi Sugiura, Toshihiko Hirano
- Journal Title
  
  Am J Chinese Med
  
  Volume: 47 Pages: 1149-1170
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K07206
[Journal Article] Vitamin K2 immunosuppressive effect on pediatric patients with atopic dermatitis2019
- Author(s)
  Wencheng Xu, Kehan Meng, Hongguang Wu, Taro Miura, Shunsuke Suzuki, Chiyotanda Masako, Sachiko Tanaka, Kentaro Sugiyama, Hisashi Kawashima, Toshihiko Hirano
- Journal Title
  
  Pediatr Int
  
  Volume: 61 Pages: 1188-1195
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K07206
[Journal Article] Effects of the tooth-coating solution and its components on the proliferation and production of inflammatory cytokines in mitogen-activated human peripheral blood mononuclear cells2019
- Author(s)
  Kentaro Sugiyama, Sachiko Wada, Sachiko Tanaka, Kaoruko Urai, Toshihiko Hirano
- Journal Title
  
  Curr Top Pharmacol
  
  Volume: 23 Pages: 93-101
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K07206
[Journal Article] Tetrandrine and cepharanthine induce apoptosis through caspase cascade regulation, cell cycle arrest, MAPK activation and PI3K/Akt/mTOR signal modification in glucocorticoid resistant human leukemia Jurkat T cells2019
- Author(s)
  Wencheng Xu W, Xiaoqin Wang, Yuanchao Tu, Hiroshi Masaki, Sachiko Tanaka, Kenji Onda, Kentaro Sugiyama, Haruki Yamada, Toshihiko Hirano
- Journal Title
  
  Chem Biol Interact
  
  Volume: 310 Pages: 108726-108726
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K07206
[Journal Article] 重症筋無力症患者におけるBAFFシグナル制御を標的とした新たな免疫抑制療法の可能性に関する検討2015
- Author(s)
  田中　祥子　井上　文増田　眞之　内海　裕也　平野　俊彦
- Journal Title
  
  臨床薬理の進歩
  
  Volume: 30 Pages: 60-64
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-24590215
[Journal Article] 重症筋無力症患者における治療効果予測因子としての末梢T・Bリンパ球の特徴付け2014
- Author(s)
  田中　祥子
- Journal Title
  
  薬学研究の進歩　薬学研究奨励財団助成研究成果報告集
  
  Volume: 30 Pages: 95-102
- Data Source
  KAKENHI-PROJECT-24590215
[Presentation] ヒト末梢血単核細胞における調整乳由来細胞外小胞による抗炎症作用に関する検討2023
- Author(s)
  穂満　怜奈、田中　祥子、鶴見　海斗、岩田　晃美、大垣　友香、神谷　太郎、遠藤　美緒、桜井　基一郎、水野　克己、恩田　健二、杉山　健太郎
- Organizer
  日本薬学会第143年会
- Data Source
  KAKENHI-PROJECT-23K06219
[Presentation] ヒトTリンパ球性白血病細胞株に対するビタミンK類の増殖抑制作用、アポトーシス誘導作用および細胞周期修飾作用2019
- Author(s)
  呉弘光、許文成、田中祥子、杉山健太郎、平野俊彦
- Organizer
  第106回新都心血液研究会
- Data Source
  KAKENHI-PROJECT-19K07206
[Presentation] 関節リウマチ患者末梢血リンパ球に対するメトトレキサートとビタミンK2の相乗的抑制効果2019
- Author(s)
  杉山健太郎、呉弘光、許文成、小野寺大樹、海老原弥咲、小宮遼太郎、田中祥子、太原恒一郎、沢田哲治、平野俊彦
- Organizer
  第98回免疫アレルギー研究会
- Data Source
  KAKENHI-PROJECT-19K07206
[Presentation] 重症筋無力症患者における制御性B細胞と治療効果との関連2014
- Author(s)
  落合　有美香，田中　祥子，増田　眞之，近藤　智子，井上　文，伊藤　傑，明石　貴雄，相澤　仁志，杉山　健太郎，平野　俊彦
- Organizer
  日本薬学会第134年会
- Place of Presentation
  熊本
- Data Source
  KAKENHI-PROJECT-24590215
[Presentation] B cell activating factor belonging to the tumor necrosis family were related to efficacy of glucocorticoid therapy in myasthenia gravis patients2012
- Author(s)
  Sachiko Tanaka, Mamiko Yamamoto, Akemi Maeno, Yumika Ochiai, Suguru Ito, Masayuki Masuda, Kenji Onda, Kentaro Sugiyama, Hiroya Utsumi, Toshihiko Hirano
- Organizer
  The 33 rd the Annual Meating of the Japanese Society of Clinical Pharmacology and Therapeutics(BPS/JSCPT Joint Symposium)
- Place of Presentation
  Naha, Japan
- Data Source
  KAKENHI-PROJECT-24590215
[Presentation] Low-dose glucocorticoid therapy complement the pituitary-adrenocortical system and reduce anxiety and insomnia in myasthenia gravis patients2012
- Author(s)
  Sachiko Tanaka, Takao Akashi,Suguru Itoh, Masayuki Masuda, Hiroya Utsumi, Chiho Kasahara, Yumika Ochiai, Mamiko Yamamoto, Hironori Takeuchi,　Sakae Unezaki and Toshihiko Hirano
- Organizer
  The 72th World Congress of Pharmacy and Pharmaceutical Sciences
- Place of Presentation
  Amsterdam, Holland
- Data Source
  KAKENHI-PROJECT-24590215
[Presentation] 重症筋無力症患者における制御性B細胞と治療効果との関連
- Author(s)
  田中　祥子，増田　眞之，落合　有美香，河合　奈々江，黒江　里歌，井上　文，伊藤　傑，相澤　仁志，明石　貴雄，恩田　健二，杉山　健太郎，平野　俊彦
- Organizer
  第35回日本臨床薬理学会学術総会
- Place of Presentation
  愛媛県　松山市
- Year and Date
  2015-12-04 – 2015-12-06
- Data Source
  KAKENHI-PROJECT-24590215

1. MASUDA Masayuki

# of Collaborated Projects: 1 results

# of Collaborated Products: 5 results
2. INOUE Aya

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
3. ITO Suguru

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
4. AIZAWA Hitoshi

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results

TANAKA SACHIKO 田中 祥子

田中 祥子 タナカ サチコ

TANAKA Sachiko 田中 祥子

Research Projects

Research Products

Co-Researchers

Research on Milk Exosome for Induction of Intestinal Immune TolerancePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Regulatory T cells and their Potential for Tolerance Induction in Myasthenia Gravis Towards Precision MedicinePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Induction of Peripheral immune tolerance in Myasthenia Gravis PatientsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Arsenic disulfide combined with L-buthionine-(S, R)-sulfoximine induces synergistic antitumor effects in two-dimensional and three-dimensional models of MCF-7 breast carcinoma cells2019

Author(s)

Journal Title

Data Source

[Journal Article] Vitamin K2 immunosuppressive effect on pediatric patients with atopic dermatitis2019

Author(s)

Journal Title

Data Source

[Journal Article] Effects of the tooth-coating solution and its components on the proliferation and production of inflammatory cytokines in mitogen-activated human peripheral blood mononuclear cells2019

Author(s)

Journal Title

Data Source

[Journal Article] Tetrandrine and cepharanthine induce apoptosis through caspase cascade regulation, cell cycle arrest, MAPK activation and PI3K/Akt/mTOR signal modification in glucocorticoid resistant human leukemia Jurkat T cells2019

Author(s)

Journal Title

Data Source

[Journal Article] 重症筋無力症患者におけるBAFFシグナル制御を標的とした新たな免疫抑制療法の可能性に関する検討2015

Author(s)

Journal Title

Data Source

[Journal Article] 重症筋無力症患者における治療効果予測因子としての末梢T・Bリンパ球の特徴付け2014

Author(s)

Journal Title

Data Source

[Presentation] ヒト末梢血単核細胞における調整乳由来細胞外小胞による抗炎症作用に関する検討2023

Author(s)

Organizer

Data Source

[Presentation] ヒトTリンパ球性白血病細胞株に対するビタミンK類の増殖抑制作用、アポトーシス誘導作用および細胞周期修飾作用2019

Author(s)

Organizer

Data Source

[Presentation] 関節リウマチ患者末梢血リンパ球に対するメトトレキサートとビタミンK2の相乗的抑制効果2019

Author(s)

Organizer

Data Source

[Presentation] 重症筋無力症患者における制御性B細胞と治療効果との関連2014

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] B cell activating factor belonging to the tumor necrosis family were related to efficacy of glucocorticoid therapy in myasthenia gravis patients2012

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] Low-dose glucocorticoid therapy complement the pituitary-adrenocortical system and reduce anxiety and insomnia in myasthenia gravis patients2012

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] 重症筋無力症患者における制御性B細胞と治療効果との関連

Author(s)

Organizer

Place of Presentation

Year and Date

TANAKA SACHIKO 田中祥子

田中祥子タナカサチコ

TANAKA Sachiko 田中祥子